Luzum, Jasmine A <br/><br/>
Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?  [electronic resource] 

 -  Journal of the American Heart Association  Mar 2016 
 - e003440 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.116.003440  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Coronary Artery Disease--drug therapy<br/>Cost-Benefit Analysis<br/>Humans<br/>Perindopril<br/>Pharmacogenetics